Pipeline

Our DARPin^® engine is an unlimited source of novel therapeutic designs. Explore our pipeline:

Candidate / Focus

Research

Preclinical

Phase 1

Phase 2

Phase 3

Rights

Ensovibep (MP0420) / COVID-19

Preclinical

MP0423 / COVID-19

Preclinical

MP0310 / FAP x 4-1BB

Phase 1

MP0317 / FAP x CD-40

Preclinical

CD3 / T-Cell targeting DARPins

Preclinical

Peptide-MHC targeting DARPins

Research

MP0250 / Multiple myeloma / PI combo

Phase 2

MP0274 / HER2+ tumors

Phase 1

Abicipar / Neovascular AMD

Phase 3

Abicipar / DME

Phase 3